Cargando…

Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis

OBJECTIVE: The aim of the present study was to compare the levels of serum neurofilament light chain (sNfL) in frontotemporal lobar degeneration (FTLD) patients of different clinical subtypes (bvFTD, PPA, and FTLD‐MND) and with or without the C9orf72 repeat expansion, and to correlate sNfL levels to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cajanus, Antti, Katisko, Kasper, Kontkanen, Aleksi, Jääskeläinen, Olli, Hartikainen, Päivi, Haapasalo, Annakaisa, Herukka, Sanna‐Kaisa, Vanninen, Ritva, Solje, Eino, Hall, Anette, Remes, Anne M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318100/ https://www.ncbi.nlm.nih.gov/pubmed/32441885 http://dx.doi.org/10.1002/acn3.51041

Ejemplares similares

Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders
por: Katisko, Kasper, et al.
Publicado: (2019)

Peripheral inflammatory markers and clinical correlations in patients with frontotemporal lobar degeneration with and without the C9orf72 repeat expansion
por: Katisko, Kasper, et al.
Publicado: (2019)

Astrocytes and Microglia as Potential Contributors to the Pathogenesis of C9orf72 Repeat Expansion-Associated FTLD and ALS
por: Rostalski, Hannah, et al.
Publicado: (2019)

Brainstem atrophy is linked to extrapyramidal symptoms in frontotemporal dementia
por: Heikkinen, Sami, et al.
Publicado: (2022)

Low Serum High-Density Lipoprotein Cholesterol Levels Associate with the C9orf72 Repeat Expansion in Frontotemporal Lobar Degeneration Patients
por: Jääskeläinen, Olli, et al.
Publicado: (2019)

Prodromal and Early bvFTD: Evaluating Clinical Features and Current Biomarkers
por: Katisko, Kasper, et al.
Publicado: (2019)

Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype
por: Katisko, Kasper, et al.
Publicado: (2022)

FTLD Patient–Derived Fibroblasts Show Defective Mitochondrial Function and Accumulation of p62
por: Leskelä, Stina, et al.
Publicado: (2021)

Modifiable potential risk factors in familial and sporadic frontotemporal dementia
por: Soppela, Helmi, et al.
Publicado: (2022)

The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD
por: Solje, Eino, et al.
Publicado: (2015)

The Association Between Distinct Frontal Brain Volumes and Behavioral Symptoms in Mild Cognitive Impairment, Alzheimer's Disease, and Frontotemporal Dementia
por: Cajanus, Antti, et al.
Publicado: (2019)

State-of-the-Art Methods and Emerging Fluid Biomarkers in the Diagnostics of Dementia—A Short Review and Diagnostic Algorithm
por: Solje, Eino, et al.
Publicado: (2021)

BV-2 Microglial Cells Overexpressing C9orf72 Hexanucleotide Repeat Expansion Produce DPR Proteins and Show Normal Functionality but No RNA Foci
por: Rostalski, Hannah, et al.
Publicado: (2020)

Cerebrospinal Fluid TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis Patients with and without the C9ORF72 Hexanucleotide Expansion
por: Junttila, Anna, et al.
Publicado: (2016)

Low Cerebrospinal Fluid Amyloid-Beta Concentration Is Associated with Poorer Delayed Memory Recall in Women
por: Haapalinna, Fanni, et al.
Publicado: (2016)

Vitamin D supplementation and serum neurofilament light chain in interferon‐beta‐1b‐treated MS patients
por: Hänninen, Katariina, et al.
Publicado: (2020)

C9orf72 Proteins Regulate Autophagy and Undergo Autophagosomal or Proteasomal Degradation in a Cell Type-Dependent Manner
por: Leskelä, Stina, et al.
Publicado: (2019)

Grey matter atrophy in patients with benign multiple sclerosis
por: Niiranen, Marja, et al.
Publicado: (2022)

Deficient neurotransmitter systems and synaptic function in frontotemporal lobar degeneration—Insights into disease mechanisms and current therapeutic approaches
por: Huber, Nadine, et al.
Publicado: (2021)

Rare PMP22 variants in mild to severe neuropathy uncorrelated to plasma GDF15 or neurofilament light
por: Palu, Edouard, et al.
Publicado: (2023)

Cerebrospinal Fluid and MRI Biomarkers in Neurodegenerative Diseases: A Retrospective Memory Clinic-Based Study
por: Kaipainen, Aku, et al.
Publicado: (2020)

Automatic MRI Quantifying Methods in Behavioral-Variant Frontotemporal Dementia Diagnosis
por: Cajanus, Antti, et al.
Publicado: (2018)

Repetitive element transcripts are elevated in the brain of C9orf72 ALS/FTLD patients
por: Prudencio, Mercedes, et al.
Publicado: (2017)

White matter lesions in FTLD: distinct phenotypes characterize GRN and C9ORF72 mutations
por: Ameur, Fatima, et al.
Publicado: (2016)

A small deletion in C9orf72 hides a proportion of expansion carriers in FTLD
por: Rollinson, Sara, et al.
Publicado: (2015)

Dipeptide repeat proteins activate a heat shock response found in C9ORF72-ALS/FTLD patients
por: Mordes, Daniel A., et al.
Publicado: (2018)

The RNA exosome complex degrades expanded hexanucleotide repeat RNA in C9orf72 FTLD/ALS
por: Kawabe, Yuya, et al.
Publicado: (2020)

Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in C9orf72 ALS/FTLD
por: Khosravi, Bahram, et al.
Publicado: (2017)

C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts
por: Costa, Beatrice, et al.
Publicado: (2020)

Circulating neurofilament is linked with morbid obesity, renal function, and brain density
por: Rebelos, Eleni, et al.
Publicado: (2022)

Plasma Neurofilament Light Chain (NF-L) Is a Prognostic Biomarker for Cortical Damage Evolution but Not for Cognitive Impairment or Epileptogenesis Following Experimental TBI
por: Heiskanen, Mette, et al.
Publicado: (2022)

Neurofilament Light Regulates Axon Caliber, Synaptic Activity, and Organelle Trafficking in Cultured Human Motor Neurons
por: Sainio, Markus T., et al.
Publicado: (2022)

The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway
por: Sullivan, Peter M., et al.
Publicado: (2016)

Drosha Inclusions Are New Components of Dipeptide-Repeat Protein Aggregates in FTLD-TDP and ALS C9orf72 Expansion Cases
por: Porta, Sílvia, et al.
Publicado: (2015)

A Pan-European Study of the C9orf72 Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability, and Intermediate Repeats
por: van der Zee, Julie, et al.
Publicado: (2013)

Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers
por: Meeter, Lieke H.H., et al.
Publicado: (2018)

C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration
por: May, Stephanie, et al.
Publicado: (2014)

Circadian sleep/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases
por: Dedeene, Lieselot, et al.
Publicado: (2019)

Using the Disease State Fingerprint Tool for Differential Diagnosis of Frontotemporal Dementia and Alzheimer's Disease
por: Muñoz-Ruiz, Miguel Ángel, et al.
Publicado: (2016)

Symmetric dimethylation of poly-GR correlates with disease duration in C9orf72 FTLD and ALS and reduces poly-GR phase separation and toxicity
por: Gittings, Lauren M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kleggm06kit2np5o8pggh7jofm